Covestor LTD Amylyx Pharmaceuticals, Inc. Transaction History

Covestor LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.62 - $2.71 $50 - $84	-31 Reduced 41.89%	43 $0
Q1 2024 May 10, 2024	SELL	$2.71 - $19.57 $9,896 - $71,469	-3,652 Reduced 98.01%	74 $0
Q4 2023 Feb 09, 2024	BUY	$12.07 - $18.46 $44,924 - $68,708	3,722 Added 93050.0%	3,726 $55,000
Q4 2022 Feb 13, 2023	SELL	$29.75 - $39.26 $29 - $39	-1 Reduced 20.0%	4 $0
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $85 - $154	5 New	5 $0

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $237M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.